Use of teicoplanin in the field of dermatology

Teicoplanin (TEIC) was used in 5 patients with skin and skin structure infection. TEIC was administered by intravenous injection of 400 mg over a 30-minute period once or twice a day on the first day of treatment followed by once a day treatment of 200mg or 400mg. Clinical response was evaluated in...

Full description

Saved in:
Bibliographic Details
Published inCHEMOTHERAPY Vol. 41; no. Supplement2; pp. 267 - 269
Main Authors Kanzaki, Hiroko, Shimoe, Keisei, Arata, Jiro, Umemura, Shigeo
Format Journal Article
LanguageJapanese
Published Japanese Society of Chemotherapy 1993
Subjects
Teicoplanin
Online AccessGet full text

Cover

More Information
Summary:Teicoplanin (TEIC) was used in 5 patients with skin and skin structure infection. TEIC was administered by intravenous injection of 400 mg over a 30-minute period once or twice a day on the first day of treatment followed by once a day treatment of 200mg or 400mg. Clinical response was evaluated in 4 patients. One patient dropped out due to superinfection with gramnegative bacilli. Overall clinical response was good in all 4 patients. Drug-induced fever was observed in one patient. Slight eosinophilia, elevation of CRP, lowering of creatinine clearance and elevation of γ-GTP were observed. All of these disappeared spontaneously after therapy.
ISSN:0009-3165
1884-5894
DOI:10.11250/chemotherapy1953.41.Supplement2_267